tiprankstipranks
Santen Pharmaceutical Co Ltd (SNPHF)
OTHER OTC:SNPHF
Holding SNPHF?
Track your performance easily

Santen Pharmaceutical Co (SNPHF) Financial Statements

6 Followers

Santen Pharmaceutical Co Financial Overview

Santen Pharmaceutical Co's market cap is currently ―. The company's EPS TTM is $0.486; its P/E ratio is 22.12; and it has a dividend yield of 2.12%. Santen Pharmaceutical Co is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue¥ 70.87B¥ 63.38B¥ 65.53B¥ 70.46B¥ 67.04B
Gross Profit¥ 41.32B¥ 35.89B¥ 37.13B¥ 43.49B¥ 37.20B
EBIT¥ 8.63B¥ -27.77B¥ 9.20B¥ 10.42B¥ 7.57B
EBITDA¥ 12.76B¥ -23.22B¥ 13.67B¥ 14.93B¥ 11.81B
Net Income Common Stockholders¥ 5.98B¥ -28.71B¥ 6.66B¥ 7.87B¥ 5.04B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 62.32B¥ 69.94B¥ 69.53B¥ 84.31B¥ 68.29B
Total Assets¥ 420.14B¥ 426.58B¥ 461.28B¥ 459.98B¥ 429.60B
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -62.32B¥ -69.94B¥ -69.53B¥ -84.31B¥ -68.29B
Total Liabilities-----
Stockholders Equity¥ 300.93B¥ 310.07B¥ 343.56B¥ 337.49B¥ 321.40B
Cash Flow-
Free Cash Flow¥ 5.41B¥ 6.24B¥ -3.83B¥ -473.00M¥ -1.92B
Operating Cash Flow¥ 10.15B¥ 15.91B¥ 2.42B¥ 14.86B¥ 4.09B
Investing Cash Flow¥ -4.79B¥ -12.59B¥ -6.23B¥ -11.93B¥ -6.18B
Financing Cash Flow¥ -11.87B¥ -2.35B¥ -13.77B¥ 9.71B¥ -7.12B
Currency in JPY

Santen Pharmaceutical Co Earnings and Revenue History

Santen Pharmaceutical Co Debt to Assets

Santen Pharmaceutical Co Cash Flow

Santen Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis